.2.2. Sperm Quantitative Parameters three.2.two. Sperm Quantitative Parameters Milt VolumeMilt No substantial differences
.2.2. Sperm Quantitative Parameters 3.2.two. Sperm Quantitative Parameters Milt VolumeMilt No significant variations in milt volume were observed amongst experimental groups Volume 24 h post-treatment. At 48 h post-treatment, the DMPO Biological Activity Concentration 24 h post-treatment followed by a substantial decrease at 48 h. Concentration within the PLGA35 group reached highest levels at 72 h, but didn’t differ from other groups at any sampling point. The PLGA200 group exhibited decrease initial sperm concentration than with CP, but did not differ from PLGA35. Drastically larger values for PLGA200 have been observed at 48 h and 72 h posttreatment compared to values at 0 h, although not differing at 48 and 72 h from other groups (Figure 5).Milt volume, mL30 a 20 a a A ten A 30 0 A B 24 48 72 a a Time post-injection, h ab a a a B A b A CP PLGA35 PLGA200 a ab a ABof 13 88 ofAnimals 2021, 11, 3305 Animals 2021, 11, xMilt volume, mLFigure four. Milt volume after hormone treatment. Significant variations among groups at a sampling a point are indicated by lowercase letters (p 0.05). Substantial variations within an experimental AB B A group are indicated byauppercase letters (p 0.05). Experimental treatments: CP–carp pituitary ten dose 4 mg/kg; PLGA35–Alarelin, dose 35 g/kg; PLGA200–Alarelin, dose 200 g/kg. extract,AAASpermatozoon Concentration A B CP 0 CP initially induced higher spermatozoon concentration 24 h post-treatment followed 24 48 72 PLGA35 by a considerable reduce at 48 h. Concentration inside the PLGA35 group reached highest PLGA200 Time post-injection, h levels at 72 h, but did not differ from other groups at any sampling point. The PLGA200 group exhibited reduce initial sperm concentration than with CP, but groups differ from Figure 4. Milt volume after hormone treatment. Significant variations amongst did notat a sampling Milt volume immediately after hormone therapy. Important point are indicated by lowercase values(p 0.05). Substantial differences at 48 h an experimental PLGA35. Drastically greater letters for PLGA200 had been observed inside and 72 h postpoint are indicated by lowercase letters (p 0.05). Substantial variations inside an experimental group are indicated by to values letters (p 0.05). Experimental treatments: CP–carp pituitary therapy compared uppercase letters despite the fact that not differing at 48 and 72 h from other group are indicated by uppercase at 0 h,(p 0.05). Experimental remedies: CP–carp pituitary extract, dose 4 mg/kg; PLGA35–Alarelin, dose 35 g/kg; PLGA200–Alarelin, dose 200 g/kg. groups (Figure five). extract, dos.
